[Study on the protective effect of HDL subclasses against lipopolysaccharide]. 2007

Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
Department of Biochemistry and Molecular Biology, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China. jlq-8@163.com

OBJECTIVE To elucidate the anti-LPS effect of high-density lipoprotein (HDL) subclasses. METHODS The pNF-kappaB-luc plasmid was transfected into HepG2 cells and the luciferase expression was obtained by the optimization of cell density, incubation time of transfected cells and stimulating concentration of LPS. The luciferase expression was examined in the cells treated with various stimulus including LPS, mixtures of HDL subclasses and LPS. The expression of TNF-alpha mRNA was detected RT-PCR. RESULTS After LPS stimulation, HDL subclasses did not show obvious influence on the effect of LPS to stimulate the luciferase production. However, pre-incubation of cells or pre-incubation of LPS with large-sized HDL(2) strongly inhibited the effect of LPS to stimulate the luciferase production. When LPS was incubated with increased concentration of HDL(2), the LPS effect was decreased to a greater extent. Pre-incubation of LPS with HDL(2) before addition to the cells resulted in a significant decrease in the mRNA level of TNF-alpha. CONCLUSIONS The largest HDL(2) has strong LPS-binding capacity and can inhibit the LPS induced TNF-alpha release in HepG2 cells; HDL(3) shows weak anti-LPS effect; small-sized prebeta(1)-HDL does not show anti-LPS effect.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D053439 Lipoproteins, HDL2 Low-density subclass of the high-density lipoproteins, with particle sizes between 8 to 13 nm. High Density Lipoprotein-2,HDL-2,HDL2 Lipoprotein,High Density Lipoprotein HDL2,Lipoprotein HDL2,HDL 2,HDL2 Lipoproteins,HDL2, Lipoprotein,High Density Lipoprotein 2,Lipoprotein, HDL2

Related Publications

Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
June 1986, Diabetes research (Edinburgh, Scotland),
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
December 2023, Nanomedicine (London, England),
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
December 1993, European heart journal,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
December 2001, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
September 1999, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
April 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
January 1986, Advances in experimental medicine and biology,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
January 2003, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
December 1984, Clinica chimica acta; international journal of clinical chemistry,
Lian-qun Jia, and Qi-ming Wang, and Chun Liu, and Li Tian, and Ming-de Fu
September 2007, Yao xue xue bao = Acta pharmaceutica Sinica,
Copied contents to your clipboard!